These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3776606)

  • 1. Glutathione peroxidase activity, associated enzymes and substrates in blood cells from patients with multiple sclerosis--effects of antioxidant supplementation.
    Jensen GE; Clausen J
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 7():450-3. PubMed ID: 3776606
    [No Abstract]   [Full Text] [Related]  

  • 2. Glutathione redox cycle enzyme activities in erythrocytes of multiple sclerosis patients.
    Di Ilio C; Arduini A; Del Boccio G; La Rovere G; Federici G
    Clin Physiol Biochem; 1986; 4(2):120-4. PubMed ID: 3698470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selenium in chronic neurologic diseases. Multiple sclerosis and Batten's disease.
    Clausen J; Jensen GE; Nielsen SA
    Biol Trace Elem Res; 1988; 15():179-203. PubMed ID: 2484516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione peroxidase and reductase, glucose-6-phosphate dehydrogenase and catalase activities in multiple sclerosis.
    Jensen GE; Clausen J
    J Neurol Sci; 1984 Jan; 63(1):45-53. PubMed ID: 6699653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose antioxidant supplementation to MS patients. Effects on glutathione peroxidase, clinical safety, and absorption of selenium.
    Mai J; Sørensen PS; Hansen JC
    Biol Trace Elem Res; 1990 Feb; 24(2):109-17. PubMed ID: 1702664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione redox cycle enzymes and selenium in severe rheumatoid arthritis: lack of antioxidative response to selenium supplementation in polymorphonuclear leucocytes.
    Tarp U; Stengaard-Pedersen K; Hansen JC; Thorling EB
    Ann Rheum Dis; 1992 Sep; 51(9):1044-9. PubMed ID: 1417134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Status of the antioxidant enzyme system in benign symmetrical lipomatosis and changes in it from the use of antioxidant therapy].
    Gavriliuk LA; Chebanu AP; Topalo VM
    Vopr Med Khim; 1995; 41(1):45-7. PubMed ID: 7771093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of smoking and vitamin E on blood antioxidant status.
    Duthie GG; Arthur JR; James WP
    Am J Clin Nutr; 1991 Apr; 53(4 Suppl):1061S-1063S. PubMed ID: 2012019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of the benefit of an antioxidant therapy in children and teenagers with Down syndrome.
    Parisotto EB; Giaretta AG; Zamoner A; Moreira EA; Fröde TS; Pedrosa RC; Filho DW
    Res Dev Disabil; 2015; 45-46():14-20. PubMed ID: 26207872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant capacity in Fasciola hepatica patients before and after treatment with triclabendazole alone or in combination with ascorbic acid (vitamin C) and tocofersolan (vitamin E).
    Rehim WM; Sharaf IA; Hishmat M; el-Toukhy MA; Rawash NA; Fouad HN
    Arzneimittelforschung; 2003; 53(3):214-20. PubMed ID: 12705178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenium glutathione peroxidase: some aspects in man.
    Michelson AM
    J Environ Pathol Toxicol Oncol; 1998; 17(3-4):233-9. PubMed ID: 9726796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cigarette smoke exposure of school children: effect of passive smoking and vitamin E supplementation on blood antioxidant status.
    Jendryczko A; Szpyrka G; Gruszczyński J; Kozowicz M
    Neoplasma; 1993; 40(3):199-203. PubMed ID: 8350969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione peroxidase activity in various types of blood cells in multiple sclerosis.
    Szeinberg A; Golan R; Ben-Ezzer J; Sarova-Pinhas I; Kindler D
    Acta Neurol Scand; 1981 Jan; 63(1):67-75. PubMed ID: 7468162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity profile of glutathione-dependent enzymes and respiratory chain complexes in rats supplemented with antioxidants and treated with carcinogens.
    Desai VG; Casciano D; Feuers RJ; Aidoo A
    Arch Biochem Biophys; 2001 Oct; 394(2):255-64. PubMed ID: 11594740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report bodes ill for antioxidant supplementation.
    Larkin M
    Lancet; 2000 Apr; 355(9213):1433. PubMed ID: 10791533
    [No Abstract]   [Full Text] [Related]  

  • 16. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or beta-carotene.
    Delmas-Beauvieux MC; Peuchant E; Couchouron A; Constans J; Sergeant C; Simonoff M; Pellegrin JL; Leng B; Conri C; Clerc M
    Am J Clin Nutr; 1996 Jul; 64(1):101-7. PubMed ID: 8669404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trials of antioxidant supplementation for cancer prevention: first bias, now chance--next, cause.
    Gann PH
    JAMA; 2009 Jan; 301(1):102-3. PubMed ID: 19066369
    [No Abstract]   [Full Text] [Related]  

  • 18. Antioxidant supplementation for lung disease in cystic fibrosis.
    Ciofu O; Lykkesfeldt J
    Cochrane Database Syst Rev; 2014 Aug; (8):CD007020. PubMed ID: 25102015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selenium content and glutathione peroxidase activity in tissues of the dairy cow after short-term feeding.
    Harrison JH; Conrad HR
    J Dairy Sci; 1984 Oct; 67(10):2464-70. PubMed ID: 6501656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selenium, glutathione-peroxidase and dermatitis herpetiformis.
    Ljunghall K; Juhlin L; Edqvist LE; Plantin LO
    Acta Derm Venereol; 1984; 64(6):546-7. PubMed ID: 6084931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.